导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -20.02% | 4399/4773 |
| 近一周 | -3.71% | 4870/5465 |
| 近一月 | -10.99% | 5342/5421 |
| 近一季 | -23.71% | 5147/5231 |
| 近半年 | -21.89% | 4483/4920 |
| 近一年 | -11.95% | 3514/4394 |
| 近两年 | 65.52% | 1093/2954 |
| 近三年 | 16.30% | 1605/2253 |
| 成立以来 | 27.64% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.08% 2104/4961 |
0.39% 3183/5312 |
- - |
- - |
| 2025 | 57.33% 287/4813 |
7.13% 517/3635 |
-0.65% 2989/4076 |
50.37% 311/4524 |
-1.70% 2995/4813 |
| 2024 | 1.11% 2025/3463 |
-7.40% 2153/2808 |
-9.99% 2410/3014 |
23.68% 375/3129 |
-1.91% 1884/3463 |
| 2023 | -27.52% 2010/2656 |
-2.50% 2000/2280 |
-5.46% 1462/2385 |
-15.27% 2220/2515 |
-7.20% 2085/2655 |
| 2022 | -28.46% 1560/2207 |
-17.25% 1192/1919 |
20.91% 35/2016 |
-23.88% 1978/2113 |
-6.06% 1975/2208 |
| 2021 | 43.90% 16/1822 |
-14.05% 1165/1255 |
46.98% 4/1330 |
14.77% 80/1466 |
-0.75% 1275/1822 |
| 2020 | - - |
- - |
- - |
- - |
- - |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 港股医疗ETF | 1.4546 | 31.90% |
| 华富中证港股通创新药指数型发起式A | 1.1637 | 30.96% |
| 天弘恒生沪深港创新药精选50ETF发起联接A | 1.3128 | 30.52% |
| 中欧中证港股通创新药指数发起A | 1.6103 | 30.52% |
| 嘉实中证港股通创新药指数发起式C | 0.8566 | 30.50% |
| 中欧中证港股通创新药指数发起C | 1.4583 | 30.44% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8927 | 30.26% |
| 景顺长城中证港股通创新药ETF联接C | 1.4696 | 29.97% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8736 | 29.94% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8719 | 29.88% |
| 博时新能源汽车ETF VS. 长安沪深300非周期A(740101) |